475 related articles for article (PubMed ID: 18249506)
1. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
Gaspard U
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
[TBL] [Abstract][Full Text] [Related]
4. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
5. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
8. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
9. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
10. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
11. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
12. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
14. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
17. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
18. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
19. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
